Why Regenerative Medicine
Traditional medical approaches often rely on removing damaged or diseased tissue and replacing it with synthetic materials or foreign implants. While effective in many cases, these methods may not always restore the body’s natural structure or function.
Regenerative medicine offers a different approach working with native tissue-based grafts to support the body’s inherent ability to repair and rebuild. Rather than replacing what is lost, these therapies aim to preserve and complement existing tissue, creating an environment that supports healing.
By leveraging naturally derived materials, regenerative medicine expands the toolkit available to healthcare providers, bridging conventional treatments with innovative, science-driven solutions.
Placental Tissue
Placental tissue, commonly referred to as birth tissue, is a remarkable, naturally occurring resource formed during pregnancy to support and protect developing life. It includes layers such as the amnion and chorion, which are rich in structural proteins, extracellular matrix components, and essential biological factors.
Following healthy, full-term deliveries often during scheduled procedures such as cesarean sections these tissues can be safely recovered from consenting donors. What was once routinely discarded can instead be donated as a generous contribution to help support medical care for others.
Birth tissues have been utilized across a wide range of clinical applications, including wound care, surgical procedures, and emerging therapeutic areas. Their unique composition and natural origin make them a valuable option in advancing regenerative medicine.
At Ponya, every tissue is carefully screened, processed, and handled in accordance with stringent regulatory and quality standards, ensuring safety, integrity, and respect for the donor’s contribution.
Tissue Integrity and Traceability
Ensuring tissue integrity and full traceability is fundamental to patient safety and product quality. Every step from donor screening and recovery to processing, storage, and distribution is performed under controlled conditions and rigorously documented.
Each graft is assigned a unique identifier, allowing it to be tracked throughout its entire lifecycle. This robust traceability system preserves critical information about the tissue’s origin, handling, and processing, supporting both regulatory compliance and clinical confidence.
Submitting TURs is an essential part of maintaining the chain of traceability. It ensures that each graft can be accounted for from donation through final use, supporting ongoing quality monitoring and regulatory requirements.
Human Tissue Allografts
Human tissue allografts are derived from donated human tissue and are used to support a variety of medical and surgical applications. These grafts are processed using validated methods designed to preserve key structural and biological characteristics while meeting stringent safety and quality standards.
Autograft vs. Xenograft vs. Allograft
Autograft
Tissue taken from the patient’s own body
- Pros: No risk of immune rejection
- Cons: Requires additional surgery and donor site morbidity
Xenograft
Tissue derived from animal sources
- Pros: Widely available
- Cons: Different biological properties, potential compatibility limitations, immune response
Allograft
Tissue donated from another human
- Pros: Readily available, no additional surgical site, biologically compatible
- Cons: Requires rigorous screening and processing
Why Allografts
Allografts offer a balance between availability and biological relevance. They eliminate the need for a secondary surgical site while providing a naturally derived matrix that integrates into clinical workflows. When sourced, processed, and tracked appropriately, they represent a safe and reliable option for supporting patient care.
Frequently Asked Questions
All tissue is recovered from healthy, consenting donors following full-term births. Donations typically occur during planned deliveries and are conducted under strict ethical and regulatory guidelines.
Yes. Tissue recovery occurs after delivery and does not interfere with standard medical care for either the mother or child.
Donors undergo comprehensive screening, including medical and social history reviews, as well as laboratory testing, in accordance with federal regulations and industry standards.
Recovered tissue is processed in controlled environments using validated methods designed to maintain integrity while meeting strict safety and quality requirements.
Traceability ensures that every graft can be tracked from donor to final use. This supports patient safety, regulatory compliance, and rapid response if any issue arises.
Allografts are used by healthcare professionals across a variety of settings, including wound care, surgery, and other medical specialties.
Allografts are biologically derived and designed to work in harmony with the body, whereas synthetic materials are manufactured and may not replicate natural tissue structure.